Home | Industry & Reform | Public health buffeted by free-trade winds

Public health buffeted by free-trade winds

Australia's pharmaceutical benefits scheme is being challenged by lobbying from US industry, writes Patricia Ranald.

Please login below to view content or subscribe now.

Membership Login

Get the news delivered straight to your inbox

Receive the top stories in our weekly newsletter Sign up now